Compare ADMA & CENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADMA | CENTA |
|---|---|---|
| Founded | 2004 | 1955 |
| Country | United States | United States |
| Employees | N/A | 6000 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Consumer Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.3B |
| IPO Year | 2012 | N/A |
| Metric | ADMA | CENTA |
|---|---|---|
| Price | $8.27 | $38.45 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 4 |
| Target Price | $25.67 | ★ $36.75 |
| AVG Volume (30 Days) | ★ 3.0M | 341.6K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.19 | N/A |
| Revenue | ★ $42,219,783.00 | N/A |
| Revenue This Year | $27.46 | $1.60 |
| Revenue Next Year | $22.11 | $2.04 |
| P/E Ratio | $44.05 | ★ $13.52 |
| Revenue Growth | ★ 43.85 | N/A |
| 52 Week Low | $7.21 | $25.97 |
| 52 Week High | $20.46 | $39.99 |
| Indicator | ADMA | CENTA |
|---|---|---|
| Relative Strength Index (RSI) | 38.31 | 54.17 |
| Support Level | $8.23 | $36.52 |
| Resistance Level | $8.97 | $39.99 |
| Average True Range (ATR) | 0.26 | 1.30 |
| MACD | -0.08 | -0.10 |
| Stochastic Oscillator | 8.58 | 46.22 |
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.
Central Garden & Pet Co offers solutions that support healthier pets, greener lawns, and thriving gardens. Its products include dog and cat treats, chews, toys, beds, containment, grooming supplies, aquatics, small animal and bird supplies, equine and livestock products, insect control solutions, grass seed, wild bird feed, fertilizers, pest controls, live plants, and packet seeds, sold under brands such as Aqueon, Nylabone, Kaytee, Farnam, Pennington, Ferry Morse, Amdro, and Sevin. The company operates through two segments, Pet and Garden, and sells through retailers, independent stores, eCommerce channels, and professional markets. It has sales and distribution operations mainly across the United States, with additional facilities in Canada and Mexico.